What is Cullinan Oncology LLC (CGEM) stock price today?

Cullinan Oncology LLC (CGEM) currently trades at $12.85 per share. The stock has a market capitalization of $837.68M and a P/E ratio of —x.

Is CGEM stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, Cullinan Oncology LLC has a Smart Value Score of 28/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is —/9 and Altman Z-Score is —.

CGEM

Cullinan Oncology LLC

NASDAQ: CGEM · HEALTHCARE · BIOTECHNOLOGY

$12.85

+0.31% today

Updated 2026-04-29

Market cap

$837.68M

P/E ratio

—

P/S ratio

25.86x

EPS (TTM)

$-3.36

Dividend yield

—

52W range

$6 – $17

Volume

0.8M

Market cap

$837.68M

P/E ratio

—

P/S ratio

25.86x

EPS (TTM)

$-3.36

Dividend yield

—

52W range

$6 – $17

Volume

0.8M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

4.3

Growth

5.0

Quality

C+

3.0

Profitability

5.0

Valuation

C+

—/9

Piotroski F-Score

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →201 stocks currently score above 75

Price targets

Analyst target

$31.35

+143.97%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

1 Strong Buy11 Buy0 Hold0 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths

Insufficient data

Risks

- Thin margins at 0.00%

- Negative free cash flow $-38.12M

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$0.00	$0.00	$0.00	$0.00	$0.00
Net income	$111.21M	$-153.16M	$-167.38M	$-219.88M	$-50.71M
EPS	—	—	—	—	$-3.36
Free cash flow	$-127.80M	$-134.48M	$-145.30M	$-175.80M	$-38.12M
Profit margin	—	—	—	—	—

Recent insider activity

Date	Insider	Type	Shares	Price
2026-03-05	MICHAELSON, JENNIFER	Sale	4,000	—
2026-03-05	MICHAELSON, JENNIFER	Sale	8,000	$15.68
2026-03-05	MICHAELSON, JENNIFER	Buy	4,000	$4.30

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
CGEM	$837.68M	28	4.3	3.0	5.0	5.0	—	Avoid
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$322.34B	54	5.3	5.5	7.3	4.8	+42.06%	Buy
AZN	$294.17B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

Cullinan Oncology LLC trades at $12.85. Our Smart Value Score of 28/100 indicates the stock is weak.

Frequently asked questions

What is Cullinan Oncology LLC's stock price?

Cullinan Oncology LLC (CGEM) trades at $12.85.

Is Cullinan Oncology LLC overvalued?

Smart Value Score 28/100 (Grade F, Strong Sell).

What is the price target of Cullinan Oncology LLC (CGEM)?

The analyst target price is $31.35, representing +144.0% upside from the current price of $12.85.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio25.86x

ROE-44.00%

Beta-0.11

50D MA$14.08

200D MA$10.09

Shares out0.06B

Float0.04B

Short ratio—

Avg volume0.8M

Performance

1 week-1.08%

1 month-9.85%

3 months+7.47%

YTD+23.77%

1 year—

3 years—

5 years—

Compare

CGEM vs LLY →CGEM vs JNJ →CGEM vs ABBV →Stock screener →